Amy Franke
Chief Tech/Sci/R&D Officer bei SHATTUCK LABS, INC.
Profil
Amy Franke is currently the Vice President-Clinical Operations at Shattuck Labs, Inc. She previously worked as the Senior Director-Strategy & Planning at Labcorp Drug Development, Inc., Vice President-Clinical Operations at NervGen Pharma Corp., and Vice President-Clinical Operations at Aravive, Inc. Ms. Franke completed her undergraduate degree at the University of Michigan and her graduate degree at the University of Pennsylvania Medical Center.
Aktive Positionen von Amy Franke
| Unternehmen | Position | Beginn |
|---|---|---|
| SHATTUCK LABS, INC. | Chief Tech/Sci/R&D Officer | 01.10.2022 |
Ehemalige bekannte Positionen von Amy Franke
| Unternehmen | Position | Ende |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 01.08.2022 |
| COVANCE INC. | Corporate Officer/Principal | - |
| NERVGEN PHARMA CORP. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Amy Franke
| University of Michigan | Undergraduate Degree |
| University of Pennsylvania Medical Center | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SHATTUCK LABS, INC. | Health Technology |
| NERVGEN PHARMA CORP. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
